BMJ article on Eltroxin reformulation - apparently it's all in patients' heads

[Guest guest]

Just noticed this recent article written by some psychosomatic (!!!) researchers

that states that the worsening symptoms experienced by patients after the

reformulation of Eltroxin (mainly affected NZ thyroid sufferers in 2008) was all

in the patients' heads.

Just to quote a bit from the article.....

" People with higher levels of emotional distress and anxiety are more likely to

attribute physical symptoms to a medical intervention or illness.2 Hypothyroid

patients, even those taking thyroxine replacement therapy, have been found to

have greater levels of emotional distress and more physical symptoms than people

without hypothyroidism.3 The formulation change itself is likely to have caused

additional anxiety for patients, as the new formulation was the only thyroxine

treatment available, and many people were unaware that their pills were going to

change.

It seems likely that many patients taking Eltroxin in New Zealand misattributed

unrelated physical symptoms to the new formulation. Additionally, symptoms that

resulted from possible small differences in bioequivalence may have been

misattributed as harmful adverse effects rather than an indication that the dose

of thyroxine required re-evaluation. "

They got help with their article from Simon Wesseley - the idiot doctor who has

consigned UK ME patients to a life of misery saying that their ME/CFS is all in

their heads!!